BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/27/2021 5:24:00 AM | Browse: 655 | Download: 1708
 |
Received |
|
2021-05-27 12:27 |
|
Peer-Review Started |
|
2021-05-27 12:27 |
|
First Decision by Editorial Office Director |
|
2021-07-06 01:59 |
|
Return for Revision |
|
2021-07-06 01:59 |
|
Revised |
|
2021-07-07 14:40 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-11-22 03:33 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-11-25 02:26 |
|
Articles in Press |
|
2021-11-25 02:26 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-12-13 08:56 |
|
Publish the Manuscript Online |
|
2021-12-27 05:24 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pediatrics |
| Manuscript Type |
Retrospective Study |
| Article Title |
Use of oral vancomycin in children with autoimmune liver disease: A single centre experience
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Angelo Di Giorgio, Anna Tulone, Emanuele Nicastro, Lorenzo Norsa, Aurelio Sonzogni and Lorenzo D'Antiga |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Angelo Di Giorgio, MD, PhD, N/A, N/A, Pediatric Hepatology, Gastroenterology and Transplantation, Hospital Papa Giovanni XXIII , Piazza Oms 1, Bergamo 24127, Italy. adigiorgio@asst-pg23.it |
| Key Words |
Autoimmune hepatitis; Autoimmune sclerosing cholangitis; Autoimmune liver disease; Vancomycin; Children; Liver transplantation |
| Core Tip |
Experience with oral vancomycin in children with autoimmune liver disease (AILD) is limited. We enrolled 75 children [median age 10.5 years (5.6-13.4)], 54 with autoimmune hepatitis and 21 with autoimmune sclerosing cholangitis; 63/75 achieved remission by standard immunosuppressive (IS) therapy, whereas 12/75 (16%) required oral vancomycin treatment (OVT). In 6/12 patients (50%) the response was complete, whereas it was partial in 2/12 (17%), and absent in 4/12 (33%). Overall OVT increased the remission rate of the whole group of AILD patients from 81% to 92%. OVT may represent a valuable treatment option in children with AILD who do not respond to standard IS. |
| Publish Date |
2021-12-27 05:24 |
| Citation |
Di Giorgio A, Tulone A, Nicastro E, Norsa L, Sonzogni A, D'Antiga L. Use of oral vancomycin in children with autoimmune liver disease: A single centre experience. World J Hepatol 2021; 13(12): 2113-2127 |
| URL |
https://www.wjgnet.com/1948-5182/full/v13/i12/2113.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v13.i12.2113 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
